| Authors: |
Fodder K; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK., Smith HMG; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK., Yaman U; UK Dementia Research Institute, London, UK., Piras IS; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Murthy M; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK., Hardy J; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute, London, UK., Lashley T; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK., de Silva R; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK., Salih DA; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute, London, UK., Bettencourt C; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK. c.bettencourt@ucl.ac.uk. |
